Dr. Snutch’s ground-breaking translational research focuses on Frontotemporal Dementia (FTD), a devastating neurodegenerative disease. Employing animal models, his research aims to test the effectiveness of Z944, a Stage 3 drug that his lab designed to address hyperexcitability in neurons, a feature linked to FTD dementia progression. If successful, this research could potentially pave the way for a promising therapeutic option for FTD patients within just 2-3 years.
